Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

JAK2 V617F

Clinical trials for JAK2 V617F explained in plain language.

Never miss a new study

Get alerted when new JAK2 V617F trials appear

Sign up with your email to follow new studies for JAK2 V617F, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1
Sort by
  • New blood thinners battle aspirin to stop deadly clots in cancer patients

    Prevention Recruiting now

    This large Phase 3 trial aims to prevent life-threatening blood clots in people with certain high-risk blood cancers. It will compare newer, more potent blood thinners (apixaban/rivaroxaban) against standard low-dose aspirin in over 1,300 patients. The goal is to see if the newer…

    Matched conditions: JAK2 V617F

    Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Prevention

    Last updated Mar 30, 2026 14:34 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space